McKesson
One Post Street
San Francisco
California
94104
United States
Tel: 415-983-8982
Fax: 415-983-8900
Website: http://www.mckesson.com/
352 articles with McKesson
-
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
6/23/2022
Proposed joint venture aims to expand clinical research services to improve cancer treatment options for patients.
-
McKesson Reports Fiscal 2022 Fourth-Quarter Results
5/5/2022
McKesson Corporation has released its fiscal 2022 fourth-quarter financial results.
-
Over the past several years, The Lone Star State has been growing in significance as a life sciences hub. Now the industry is flocking to Hays County and its Innovation Corridor.
-
McKesson Declares Quarterly Dividend - Apr 28, 2022
4/28/2022
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.
-
McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date
4/7/2022
McKesson Corporation announced that it has closed the transaction announced in November 2021 to sell its UK businesses to AURELIUS.
-
McKesson’s Board of Directors Elects W. Roy Dunbar as New Director
4/1/2022
McKesson Corporation announced that the McKesson board of directors has elected W. Roy Dunbar as director and member of the Audit and Governance Committees, effective April 1, 2022.
-
McKesson Designated by CMS as 2022 Qualified Clinical Data Registry
2/8/2022
For the sixth consecutive year, McKesson has received approval from The Centers for Medicare & Medicaid Services to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry.
-
McKesson Declares Quarterly Dividend - Jan 27, 2022
1/27/2022
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.
-
McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
1/18/2022
McKesson Corporation announced that the McKesson board of directors elected James H. Hinton and Kathleen Wilson-Thompson as directors on Jan. 13, 2022.
-
McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference
12/29/2021
McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2022 financial results after market close on Wednesday, February 2, 2022.
-
McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH
12/20/2021
McKesson Corporation announced that it has entered into an agreement to sell its Austrian business to Quadrifolia Management GmbH.
-
McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS
11/1/2021
McKesson Corporation (NYSE: MCK) today announced that it has entered into an agreement to sell its UK businesses to AURELIUS
-
McKesson Declares Quarterly Dividend - Oct 28, 2021
10/28/2021
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.
-
Teva Pharmaceuticals reached a $15 million agreement with the state of Louisiana to settle claims against the company over its marketing of opioid products.
-
Mckesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director
9/7/2021
McKesson Corporation (NYSE:MCK) announced today that the McKesson board of directors has elected Dr. Richard H. Carmona as an independent director and member of the board’s Compensation and Compliance Committees, effective Sept. 6, 2021.
-
McKesson Reports Fiscal 2022 First-Quarter Results
8/4/2021
As previously announced, the company will host a live webcast of the earnings conference call for investors , Wednesday, August 4th at 4:30 PM ET to review its financial results.
-
Total payment amounts are contingent on the number of governments that will agree to suspend their lawsuits as part of the deal.
-
Theranos founder Elizabeth Holmes is back in the courtroom for the first time in 15 months for a three-day hearing ahead of her criminal fraud trial.
-
McKesson Declares Quarterly Dividend - Apr 29, 2021
4/29/2021
The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 42 cents per share of common stock.
-
McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
4/1/2021
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.